Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
- PMID: 16269335
- DOI: 10.1016/j.cell.2005.08.011
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
Abstract
Hypermethylated in cancer 1 (HIC1) is an epigenetically regulated transcriptional repressor that functionally cooperates with p53 to suppress age-dependent development of cancer in mice. Here we show that the mechanism by which the loss of HIC1 function promotes tumorigenesis is via activating the stress-controlling protein SIRT1 and thereby attenuating p53 function. HIC1 forms a transcriptional repression complex with SIRT1 deacetylase, and this complex directly binds the SIRT1 promoter and represses its transcription. Inactivation of HIC1 results in upregulated SIRT1 expression in normal or cancer cells; this deacetylates and inactivates p53, allowing cells to bypass apoptosis and survive DNA damage. Inhibition of SIRT1 function in cells without HIC1 abolishes the resistance to apoptosis. Since aging increases promoter hypermethylation and epigenetic silencing of HIC1, we speculate that the resultant upregulation of SIRT1 may be a double-edged sword that both promotes survival of aging cells and increases cancer risk in mammals.
Similar articles
-
Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.Bull Cancer. 2009 Nov;96(11):E66-72. doi: 10.1684/bdc.2009.0959. Bull Cancer. 2009. PMID: 19822477 Review.
-
Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.Neoplasia. 2009 Aug;11(8):763-70. doi: 10.1593/neo.09470. Neoplasia. 2009. PMID: 19649206 Free PMC article.
-
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.Cancer Cell. 2004 Oct;6(4):387-98. doi: 10.1016/j.ccr.2004.08.030. Cancer Cell. 2004. PMID: 15488761
-
The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.Mol Cancer Res. 2009 Jun;7(6):916-22. doi: 10.1158/1541-7786.MCR-08-0359. Epub 2009 Jun 2. Mol Cancer Res. 2009. PMID: 19491197
-
[Chromosome arm 17p13.3: could HIC1 be the one ?].Med Sci (Paris). 2006 Jan;22(1):54-61. doi: 10.1051/medsci/200622154. Med Sci (Paris). 2006. PMID: 16386221 Review. French.
Cited by
-
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.Theranostics. 2024 Oct 14;14(17):6726-6767. doi: 10.7150/thno.100667. eCollection 2024. Theranostics. 2024. PMID: 39479446 Free PMC article. Review.
-
Therapeutic upregulation of DNA repair pathways: strategies and small molecule activators.RSC Med Chem. 2024 Oct 11. doi: 10.1039/d4md00673a. Online ahead of print. RSC Med Chem. 2024. PMID: 39430950 Free PMC article. Review.
-
Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy.Pharmaceutics. 2024 Aug 29;16(9):1142. doi: 10.3390/pharmaceutics16091142. Pharmaceutics. 2024. PMID: 39339179 Free PMC article.
-
The dual role of sirtuins in cancer: biological functions and implications.Front Oncol. 2024 Jun 14;14:1384928. doi: 10.3389/fonc.2024.1384928. eCollection 2024. Front Oncol. 2024. PMID: 38947884 Free PMC article. Review.
-
LARP7 overexpression alleviates aortic senescence and atherosclerosis.J Cell Mol Med. 2024 Jun;28(11):e18388. doi: 10.1111/jcmm.18388. J Cell Mol Med. 2024. PMID: 38818612 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
